Archives for October 22, 2006

← 2006

Overcoming intellectual property phobia in China

By  Kirsty Barnes

China is a big market with a lot of potential but many pharma industry firms still avoid doing business in the country because of fears that their intellectual property (IP) cannot be protected.

FDA gets tougher on new drug approvals

By  Emilie Reymond

Fewer first cycle new drug approvals by the US Food and Drug Administration (FDA) could be the first evidence of a toughening regulatory environment, according to new research.

Contamination risks challenge clinical supply manufacturers

By  Emilie Reymond

Minimising the risk of cross-contamination in the production of medicines for use in clinical trials is a major challenge for manufacturers, who need to implement safety measures in order to avoid production failure.